Alta Life Sciences and CDTI invest €7.6M in Accure Therapeutics, a new company that will develop a portfolio of new medicines to address CNS diseases. Accure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The […]

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space – an emerging area in cancer immunology. The seller will retain the Northern Biologics name and will continue to […]

It is always a pleasure seeing how new clients choose Metrix Partners to help them manage finance in a strategic way, and with best practices straight from the best peers in SaaS, healthcare, DTC and other business models. The last few months have been specially active and we are proud to welcome Tropicfeel, Woffu, Quality […]

 techspert.io, the first AI-driven technology for mapping the world‘s expertise and connecting businesses directly to the source of technical and market insights, has raised £3.76 million Series A funding.  Founded in 2016, techspert.io eliminates the limitations of human-led market research with AI–driven science. Deep search technology uses reinforcement learning models to autonomously crawl online content and data, mapping expertise in real-time and precisely matching specialists to business […]

Facebook acquires Spanish cloud video gaming company PlayGiga. A Facebook spokesperson confirmed the deal to CNBC, after Spanish business newspaper Cinco Dias reported that the acquisition was coming. Read the Techcrunch article here.

 World Mastery, a content-as-a-service platform which provides structured online courses, has secured a €3M Series A round led by Pan-European VC Nauta Capital. The edtech company serves the non-academic learning needs of businesses and professionals by providing access to highly-curated specialist courses delivered by maestros – renowned experts – in subjects including tennis, basketball, dance, yoga, fitness, cooking and hairstyle. Read the full story here

Our client Onna Technologies raised a massive $11 m series A round with participation by Nauta Capital, Dawn Capital and the corporate VC arms of Dropbox and Slack. More information here

This is undoubtedly one of the highest profile transactions in the Spanish startup ecosystem this year. Keyfactor is invested by Insight Partners, and the purchase of Redtrust creates a very nice combination in a space that is red hot… digital certificates are and will be EVERYWHERE. Read more about the Keyfactor acquisition here

We welcome Psious to our client list. This Barcelona-based VR startup has recently raised EUR 8m in a round led, among others, by Asabys, CCR abd Sabadell VC. Read the full article here

Biotech startup Ona Therapeutics raises EUR1.5m from Sabadell Asabys and joins our client list. Ona Therapeutics develops novel drugs for the treatment of metastatic cancer. Read the full article here.

zenloop, a German customer experience management platform, has raised $6M investment led by Pan-European VC, Nauta Capital with Piton Capital also joining the round. The investment will be used for internationalisation with a focus on expansion across Europe in 2019 in addition to doubling zenloop’s team size within the year. Read the full article here

Zenjob, the Berlin-based tech startup, has raised 15 million euros in the Series B financing round, led by AXA Venture Partners. Additional capital investors are the current investors Acton Capital Partners, Redalpine, and Atlantic Labs. Zenjob helps large and medium-sized businesses find on-demand student staff with just a few clicks. The capital will be invested […]

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure. AELIX Therapeutics will investigate the safety, immunogenicity, and efficacy of AELIX Therapeutics’ HTI vaccine and Gilead´s Toll-Like Receptor 7 agonist vesatolimod (GS-9620) in HIV-infected individuals. Read the full press release here

Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced that its lead immuno-oncology antibody, MSC-1, began clinical testing at Memorial Sloan Kettering Cancer Center with plans to soon expand to other world-leading sites in Canada and Europe. MSC-1 is a humanized antibody against a soluble cytokine called LIF (see “About LIF” below). LIF […]

  Location intelligence SaaS company, Geoblink, has today announced that it has secured a $6m boost from Elaia Partners and existing investor Nauta Capital. The round includes grants from the Government of Madrid and Neotec CDTI, a public organisation for technology development in Spain. Founded in 2015, the European startup will use the funding to […]

Note: this article was originally published in Medium by Christophe Janz, from Point Nine Capital What does it take to raise capital, in SaaS, in 2018? UPDATE: The 2018 napkin has been published. You can download (and upvote 😉 ) it here: https://www.producthunt.com/posts/saas-funding-napkin-2018 About two years ago I thought about the question of what it takes to raise capital, in […]

Post originally published in Nauta Capital’s blog on 06 Dec 2017 ForceManager raises $12m in Series B Funding led by AXA Strategic Ventures Barcelona, 6th December 2017 – ForceManager, the first AI conversational sales assistant app for field sales teams, announced today a Series B investment worth $12m led by AXA Strategic Ventures. Additional support will be […]

This post was originally pubished in A16Z’s blog here. Many CEOs think the chief financial officer (CFO) is a utility position… and they’re dead wrong. It’s easy to see the CFO as a glorified “scorekeeper” reporting arrears on things like revenue, expenses, profit/losses, and cash flow/burn. But this work is actually a very small part of a […]

Spanish biotechnology firm Aelix Therapeutics has commenced patient enrolment in a Phase I clinical trial (AELIX-002) of HTI vaccine to treat patients infected with HIV. Designed by the firm’s chief scientific officer Dr Christian Brander and colleagues, HTI vaccine immunogen combines specific HIV regions that are enriched with T-cell responses in individuals who can control […]